These properties confer the ability of FOXA1 to act as a pioneer factor for both estrogen receptor α [10,11] and androgen receptor [12], controlling their binding, location, and function in breast and prostate cancer respectively. The gene discussed is FOXA1; the disease is prostate carcinoma.